Charlotte's Web (CWBHF) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenue was $12.6M, down 11.9% year-over-year but up 2.4% sequentially, marking a second consecutive quarter of growth.

• Net loss for Q3 2024 was $5.8M, improved from $15.1M in Q3 2023.

• New product launches, including CBN gummies, Soft Gel Capsules, and Functional Mushroom Gummies, diversified offerings and targeted new consumer segments.

• Expanded omni-channel strategy, integrating DTC, retail, and healthcare channels, and entered Canadian market via Tilray partnership.

• Cost reduction measures and operational efficiencies, including CBD oil price reductions, supported margin improvement.

Financial highlights

• Q3 2024 revenue was $12.6M, down 11.9% year-over-year; nine-month revenue was $37.0M, down 21.8%.

• Gross margin for Q3 2024 was 53.0%, down from 55.5% in Q3 2023.

• Operating loss for Q3 2024 was $6.0M, improved from $12.0M in Q3 2023.

• SG&A expenses for Q3 2024 were $12.7M, down 36% year-over-year.

• Cash and cash equivalents at September 30, 2024 were $24.6M, down from $47.8M at year-end 2023.

Outlook and guidance

• Operating expenses for 2024 expected to be over $20M lower than 2023 due to efficiency improvements and cost controls.

• Management anticipates meeting liquidity requirements for at least the next twelve months through cash on hand and operations.

• In-house production of gummies to commence, expected to improve gross margins and support innovation.

• Ongoing regulatory changes in several states, including California, may impact product formulations, packaging, and revenue.